MD’s empathy may affect patient outcomes MRSA reports in media affect MDs’ practices New type of self-harming disorder observed in teens Abused girls embed objects in their skin to deal with trauma Ob/gyn should have altered plan in finding endometriosis, not fibroid MD went ahead with hysterectomy instead of fertility-sparing options Program tackles weight gain woes in pregnancy Putting the brakes on smoking Testing the waters for new test tactics Is your med school ready to make exams more fun? Transapical aortic valve surgery a less invasive option in high-risk patients B.C. government and BCPhA announce drug-pricing agreement B.C. reveals changes to pricing and reimbursement of new generics and a frequent-dispensing policy. New pediatric indication for Reyataz Bristol-Myers Squibb's Reyataz is now indicated for the treatment of HIV-1 infection in children six to 18 years of age. Phase 1 of Alberta's new Pharmaceutical Strategy introduced Alberta Health and Wellness Minister Ron Liepert announced details of the first phase of the province's major new pharmaceutical strategy on December 8. Stelara approved for psoriasis Canada is the first country worldwide to approve Janssen-Ortho's Stelara for the treatment of psoriasis. First Previous 1959 1960 1961 1962 1963 Next Last
